Abstract
Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.
| Original language | English (US) |
|---|---|
| Article number | 28 |
| Journal | Cardiovascular Diabetology |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 26 2015 |
Fingerprint
Keywords
- China
- Control
- Diabetes
- Dyslipidemia
- Hypertension
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Endocrinology, Diabetes and Metabolism
Cite this
Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes : A national representative population study. / Wang, Tiange; Xu, Yu; Xu, Min; Wang, Weiqing; Bi, Yufang; Lu, Jieli; Dai, Meng; Zhang, Di; Ding, Lin; Xu, Baihui; Sun, Jichao; Zhao, Wenhua; Jiang, Yong; Wang, Limin; Li, Yichong; Zhang, Mei; Lai, Shenghan; Wang, Linhong; Ning, Guang.
In: Cardiovascular Diabetology, Vol. 14, No. 1, 28, 26.02.2015.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes
T2 - A national representative population study
AU - Wang, Tiange
AU - Xu, Yu
AU - Xu, Min
AU - Wang, Weiqing
AU - Bi, Yufang
AU - Lu, Jieli
AU - Dai, Meng
AU - Zhang, Di
AU - Ding, Lin
AU - Xu, Baihui
AU - Sun, Jichao
AU - Zhao, Wenhua
AU - Jiang, Yong
AU - Wang, Limin
AU - Li, Yichong
AU - Zhang, Mei
AU - Lai, Shenghan
AU - Wang, Linhong
AU - Ning, Guang
PY - 2015/2/26
Y1 - 2015/2/26
N2 - Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.
AB - Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.
KW - China
KW - Control
KW - Diabetes
KW - Dyslipidemia
KW - Hypertension
UR - http://www.scopus.com/inward/record.url?scp=84925186140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925186140&partnerID=8YFLogxK
U2 - 10.1186/s12933-015-0191-6
DO - 10.1186/s12933-015-0191-6
M3 - Article
VL - 14
JO - Cardiovascular Diabetology
JF - Cardiovascular Diabetology
SN - 1475-2840
IS - 1
M1 - 28
ER -